Aldeyra Therapeutics, Inc. (ALDX): Total Liabilities
$27.81M
As of 2025-12-31
$9.66M
As of 2026-06-30
-2.8%
3-year compound annual growth
+3.1%
5-year compound annual growth
+23.7%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $27.81M | -17.2% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $33.60M | +17.8% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $28.53M | -5.8% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $30.28M | +10.5% | 2024-03-07, Balance as of period end |
| 2021-12-31 | $27.40M | +14.9% | 2023-03-09, Balance as of period end |
| 2020-12-31 | $23.84M | -13.1% | 2022-03-17, Balance as of period end |
| 2019-12-31 | $27.44M | +223.8% | 2021-03-11, Balance as of period end |
| 2018-12-31 | $8.47M | +85.2% | 2020-03-12, Balance as of period end |
| 2017-12-31 | $4.57M | +29.3% | 2019-03-08, Balance as of period end |
| 2016-12-31 | $3.54M | +6.4% | 2018-03-29, Balance as of period end |
| 2015-12-31 | $3.33M | +32.9% | 2017-03-30, Balance as of period end |
| 2014-12-31 | $2.50M | -55.7% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $5.65M | n/a | 2015-03-23, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Aldeyra Therapeutics, Inc. (ALDX) | 2025-12-31 | $27.81M | -17.2% |
| Incannex Healthcare Inc. (IXHL) | 2026-06-30 | $5.61M | -20.6% |
| Corvus Pharmaceuticals, Inc. (CRVS) | 2025-12-31 | $9.91M | -72.7% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $50.21M | +12.4% |
| Werewolf Therapeutics, Inc. (HOWL) | 2025-12-31 | $44.59M | -16.7% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $9.90M | -84.6% |
| Context Therapeutics Inc. (CNTX) | 2025-12-31 | $8.02M | +180.4% |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $52.28M | -1.4% |
| Grace Therapeutics, Inc. (GRCE) | 2026-03-31 | $2.76M | -48.8% |
Compare ALDX, IXHL, CRVS, INO side by side · Screen every company in Pharmaceutical Preparations ↗